Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03948035
Title Elotuzumab in Combination With Carfilzomib, Lenalidomide and Dexamethasone (E-KRd) Versus KRd in MM
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Wuerzburg University Hospital
Age Groups: senior | adult
Covered Countries DEU | AUT

No variant requirements are available.